Aortic augmentation index is independently associated with N-terminal pro b-type natriuretic peptide in patients with peripheral arterial disease

Vascular and Endovascular Surgery

Volumn 46, Issue 8, 2012, Pages 648-653

  Shahin, Yousef ^a   Chetter, Ian ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

Author keywords

augmentation index; N terminal pro B type natriuretic peptide; peripheral arterial disease

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

AGED; AORTA; ARTERIAL STIFFNESS; ARTICLE; AUGMENTATION INDEX; BRACHIAL ARTERY; CLINICAL ARTICLE; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART RATE; HUMAN; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROTEIN BLOOD LEVEL; PULSE WAVE; RADIAL ARTERY; SYSTOLIC BLOOD PRESSURE; TONOMETRY;

AGED; ANKLE BRACHIAL INDEX; AORTA; ARTERIAL PRESSURE; BIOLOGICAL MARKERS; FEMALE; HUMANS; LINEAR MODELS; LOWER EXTREMITY; MALE; MANOMETRY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PERIPHERAL ARTERIAL DISEASE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PULSE WAVE ANALYSIS; SYSTOLE; UP-REGULATION; VASCULAR STIFFNESS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84868539615     PISSN: 15385744     EISSN: 19389116     Source Type: Journal    
DOI: 10.1177/1538574412462634     Document Type: Article

References (24)

1. Davies JI, Struthers AD. Pulse wave analysis and pulse wave velocity: a critical review of their strengths and weaknesses. J Hypertens. 2003 ; 21 (3). 463-472 (Pubitemid 36418950)
2. Yasmin Brown MJ.. Similarities and differences between augmentation index and pulse wave velocity in the assessment of arterial stiffness. QJM. 1999 ; 92 (10). 595-600
3. London GM, Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME. Arterial wave reflections and survival in end-stage renal failure. Hypertension. 2001 ; 38 (3). 434-438 (Pubitemid 34225679)
4. Weber T, Auer J, O'Rourke MF, et al. Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation. 2004 ; 109 (2). 184-189 (Pubitemid 38114137)
5. McDonagh TA, Robb SD, Murdoch DR, et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet. 1998 ; 351 (9095). 9-13 (Pubitemid 28020159)
6. Ndrepepa G, Braun S, Niemoller K, et al. Prognostic value of n-terminal pro-brain natriuretic peptide in patients with chronic stable angina. Circulation. 2005 ; 112 (14). 2102-2107 (Pubitemid 41475802)
7. Mueller T, Dieplinger B, Poelz W, Endler G, Wagner OF, Haltmayer M.. Amino-terminal pro-b-type natriuretic peptide as predictor of mortality in patients with symptomatic peripheral arterial disease: 5-year follow-up data from the linz peripheral arterial disease study. Clin Chem. 2009 ; 55 (1). 68-77
8. Bhalla MA, Chiang A, Epshteyn VA, et al. Prognostic role of b-type natriuretic peptide levels in patients with type 2 diabetes mellitus. J Am Coll Cardiol. 2004 ; 44 (5). 1047-1052 (Pubitemid 39165140)
9. Kaji Y, Miyoshi T, Doi M, et al. Augmentation index is associated with b-type natriuretic peptide in patients with paroxysmal atrial fibrillation. Hypertens Res. 2009 ; 32 (7). 611-616
10. Sakuragi S, Maruo T, Taniguchi M, et al. Radial augmentation index associated with increase in b-type natriuretic peptide in patients with hypertension. Int J Cardiol. 2008 ; 130 (3). 414-419
11. Weber M, Hamm C. Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine. Heart. 2006 ; 92 (6). 843-849 (Pubitemid 43799232)
12. Jones CR, Taylor K, Poston L, Shennan AH.. Validation of the Welch Allyn 'Vital Signs' oscillometric blood pressure monitor. J Hum Hypertens. 2001 ; 15 (3). 191-195 (Pubitemid 32181485)
13. Alpert BS.. Validation of the Welch Allyn Spot Vital Signs blood pressure device according to the ANSI/AAMI SP10: 2002. Accuracy and cost-efficiency successfully combined. Blood Press Monit. 2007 ; 12 (5). 345-347 (Pubitemid 47463886)
14. Davis PD, Dennis JL, Railton R. Evaluation of the A&D UA-767 and Welch Allyn Spot Vital Signs noninvasive blood pressure monitors using a blood pressure simulator. J Hum Hypertens. 2005 ; 19 (3). 197-203 (Pubitemid 40360935)
15. O'Rourke MF, Pauca A, Jiang XJ. Pulse wave analysis. Br J Clin Pharmacol. 2001 ; 51 (6). 507-522 (Pubitemid 32862740)
16. Pauca AL, O'Rourke MF, Kon ND. Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension. 2001 ; 38 (4). 932-937 (Pubitemid 34258696)
17. Asmar RG, London GM, O'Rourke ME, Safar ME. Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: a comparison with atenolol. Hypertension. 2001 ; 38 (4). 922-926 (Pubitemid 34258694)
18. Fantin F, Mattocks A, Bulpitt CJ, Banya W, Rajkumar C. Is augmentation index a good measure of vascular stiffness in the elderly?. Age Ageing. 2007 ; 36 (1). 43-48 (Pubitemid 47072032)
19. Vaitkevicius PV, Fleg JL, Engel JH, et al. Effects of age and aerobic capacity on arterial stiffness in healthy adults. Circulation. 1993 ; 88 (4 pt 1). 1456-1462 (Pubitemid 23296891)
20. Wilkinson IB, Mohammad NH, Tyrrell S, et al. Heart rate dependency of pulse pressure amplification and arterial stiffness. Am J Hypertens. 2002 ; 15 (1 pt 1). 24-30 (Pubitemid 34102268)
21. Denardo SJ, Nandyala R, Freeman GL, Pierce GL, Nichols WW. Pulse wave analysis of the aortic pressure waveform in severe left ventricular systolic dysfunction. Circ Heart Fail. 2010 ; 3 (1). 149-156
22. Kelly R, Daley J, Avolio A, O'Rourke M.. Arterial dilation and reduced wave reflection. Benefit of dilevalol in hypertension. Hypertension. 1989 ; 14 (1). 14-21 (Pubitemid 19175011)
23. Mueller T, Gegenhuber A, Poelz W, Haltmayer M. Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure. Heart. 2005 ; 91 (5). 606-612 (Pubitemid 40559349)
24. Otsuka T, Kawada T, Ibuki C, Kusama Y.. Radial arterial wave reflection is associated with the MEGA risk prediction score, an indicator of coronary heart disease risk, in middle-aged men with mild to moderate hypercholesterolemia. J Atheroscler Thromb. 2010 ; 17 (7). 688-694